COVID-19 THERAPEUTICAL OPTIONS: OVERVIEW ON CURRENTLY ANTI-INFLAMMATORY AND ANTICOAGULANT DRUGS USED
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Health and Society |
Texto Completo: | https://www.periodicojs.com.br/index.php/hs/article/view/454 |
Resumo: | Since December 2019, an outbreak of viral infection causing respiratory disease with a new virus, the Coronaviridae family, emerged in the city of Wuhan, China to worldwide. With initial symptoms similar to Coronavirus related to Severe Acute Respiratory Syndrome (SARS) and an increase in the speed of spread the World Health Organization (WHO) decrees a pandemic situation on March 11, 2020. Moreover, approximately 3.4 million deaths worldwide and 165 million cases were confirmed. Thus, contributing to an important global health problem responsible for changes in economic and social paradigms. There is no available treatment for COVID-19 until today. Although, several drugs are being used as alternative therapeutics against the diseases, mainly in severe cases. This review aimed to highlight the current anti-inflammatory and anticoagulant alternatives treatment measures for control of COVID 19 infection. Here we discuss the drugs, pharmacological proprieties, and the respective studies COVID-19 related, and also, several research protocols to respond and control the pandemic for the prophylaxis and treatment. |
id |
IEPP-2_fcff1309ab9b6bb8ffd8949b76554d97 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/454 |
network_acronym_str |
IEPP-2 |
network_name_str |
Health and Society |
repository_id_str |
|
spelling |
COVID-19 THERAPEUTICAL OPTIONS: OVERVIEW ON CURRENTLY ANTI-INFLAMMATORY AND ANTICOAGULANT DRUGS USEDCOVID-19 THERAPEUTICAL OPTIONS: OVERVIEW ON CURRENTLY ANTI-INFLAMMATORY AND ANTICOAGULANT DRUGS USEDCOVID-19; Therapeutic Approaches; Drug TherapyCOVID-19Therapeutic ApproachesDrug TherapySince December 2019, an outbreak of viral infection causing respiratory disease with a new virus, the Coronaviridae family, emerged in the city of Wuhan, China to worldwide. With initial symptoms similar to Coronavirus related to Severe Acute Respiratory Syndrome (SARS) and an increase in the speed of spread the World Health Organization (WHO) decrees a pandemic situation on March 11, 2020. Moreover, approximately 3.4 million deaths worldwide and 165 million cases were confirmed. Thus, contributing to an important global health problem responsible for changes in economic and social paradigms. There is no available treatment for COVID-19 until today. Although, several drugs are being used as alternative therapeutics against the diseases, mainly in severe cases. This review aimed to highlight the current anti-inflammatory and anticoagulant alternatives treatment measures for control of COVID 19 infection. Here we discuss the drugs, pharmacological proprieties, and the respective studies COVID-19 related, and also, several research protocols to respond and control the pandemic for the prophylaxis and treatment.Since December 2019, an outbreak of viral infection causing respiratory disease with a new virus, the Coronaviridae family, emerged in the city of Wuhan, China to worldwide. With initial symptoms similar to Coronavirus related to Severe Acute Respiratory Syndrome (SARS) and an increase in the speed of spread the World Health Organization (WHO) decrees a pandemic situation on March 11, 2020. Moreover, approximately 3.4 million deaths worldwide and 165 million cases were confirmed. Thus, contributing to an important global health problem responsible for changes in economic and social paradigms. There is no available treatment for COVID-19 until today. Although, several drugs are being used as alternative therapeutics against the diseases, mainly in severe cases. This review aimed to highlight the current anti-inflammatory and anticoagulant alternatives treatment measures for control of COVID 19 infection. Here we discuss the drugs, pharmacological proprieties, and the respective studies COVID-19 related, and also, several research protocols to respond and control the pandemic for the prophylaxis and treatment.Editora Acadêmica Periodicojs2021-09-28info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.periodicojs.com.br/index.php/hs/article/view/45410.51249/hes01.04.2021.454Health and Society; Vol. 1 No. 04 (2021)Health and Society; v. 1 n. 04 (2021)2763-572410.51249/hs.v1i04reponame:Health and Societyinstname:Instituto de Ensino e Pesquisa Periodicojsinstacron:IEPPporhttps://www.periodicojs.com.br/index.php/hs/article/view/454/323Copyright (c) 2021 Health and Societyinfo:eu-repo/semantics/openAccessLeite Guedes, Idrys HenriqueDantas dos Santos , GregórioFreire Viana, Antônio Bonildoda Silva Araújo, GeldaneCâmara Pinto dos Santos, TálioGonçalves Moreno, Cláudia JassicaTavares Donato, Silvia2022-01-11T13:27:40Zoai:ojs.pkp.sfu.ca:article/454Revistahttps://www.periodicojs.com.br/index.php/hs/PRIhttps://www.periodicojs.com.br/index.php/hs/oaijournalofhealthandsociety@gmail.com || periodicojs@gmail.com2763-57242763-5724opendoar:2022-01-11T13:27:40Health and Society - Instituto de Ensino e Pesquisa Periodicojsfalse |
dc.title.none.fl_str_mv |
COVID-19 THERAPEUTICAL OPTIONS: OVERVIEW ON CURRENTLY ANTI-INFLAMMATORY AND ANTICOAGULANT DRUGS USED COVID-19 THERAPEUTICAL OPTIONS: OVERVIEW ON CURRENTLY ANTI-INFLAMMATORY AND ANTICOAGULANT DRUGS USED |
title |
COVID-19 THERAPEUTICAL OPTIONS: OVERVIEW ON CURRENTLY ANTI-INFLAMMATORY AND ANTICOAGULANT DRUGS USED |
spellingShingle |
COVID-19 THERAPEUTICAL OPTIONS: OVERVIEW ON CURRENTLY ANTI-INFLAMMATORY AND ANTICOAGULANT DRUGS USED Leite Guedes, Idrys Henrique COVID-19; Therapeutic Approaches; Drug Therapy COVID-19 Therapeutic Approaches Drug Therapy |
title_short |
COVID-19 THERAPEUTICAL OPTIONS: OVERVIEW ON CURRENTLY ANTI-INFLAMMATORY AND ANTICOAGULANT DRUGS USED |
title_full |
COVID-19 THERAPEUTICAL OPTIONS: OVERVIEW ON CURRENTLY ANTI-INFLAMMATORY AND ANTICOAGULANT DRUGS USED |
title_fullStr |
COVID-19 THERAPEUTICAL OPTIONS: OVERVIEW ON CURRENTLY ANTI-INFLAMMATORY AND ANTICOAGULANT DRUGS USED |
title_full_unstemmed |
COVID-19 THERAPEUTICAL OPTIONS: OVERVIEW ON CURRENTLY ANTI-INFLAMMATORY AND ANTICOAGULANT DRUGS USED |
title_sort |
COVID-19 THERAPEUTICAL OPTIONS: OVERVIEW ON CURRENTLY ANTI-INFLAMMATORY AND ANTICOAGULANT DRUGS USED |
author |
Leite Guedes, Idrys Henrique |
author_facet |
Leite Guedes, Idrys Henrique Dantas dos Santos , Gregório Freire Viana, Antônio Bonildo da Silva Araújo, Geldane Câmara Pinto dos Santos, Tálio Gonçalves Moreno, Cláudia Jassica Tavares Donato, Silvia |
author_role |
author |
author2 |
Dantas dos Santos , Gregório Freire Viana, Antônio Bonildo da Silva Araújo, Geldane Câmara Pinto dos Santos, Tálio Gonçalves Moreno, Cláudia Jassica Tavares Donato, Silvia |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Leite Guedes, Idrys Henrique Dantas dos Santos , Gregório Freire Viana, Antônio Bonildo da Silva Araújo, Geldane Câmara Pinto dos Santos, Tálio Gonçalves Moreno, Cláudia Jassica Tavares Donato, Silvia |
dc.subject.por.fl_str_mv |
COVID-19; Therapeutic Approaches; Drug Therapy COVID-19 Therapeutic Approaches Drug Therapy |
topic |
COVID-19; Therapeutic Approaches; Drug Therapy COVID-19 Therapeutic Approaches Drug Therapy |
description |
Since December 2019, an outbreak of viral infection causing respiratory disease with a new virus, the Coronaviridae family, emerged in the city of Wuhan, China to worldwide. With initial symptoms similar to Coronavirus related to Severe Acute Respiratory Syndrome (SARS) and an increase in the speed of spread the World Health Organization (WHO) decrees a pandemic situation on March 11, 2020. Moreover, approximately 3.4 million deaths worldwide and 165 million cases were confirmed. Thus, contributing to an important global health problem responsible for changes in economic and social paradigms. There is no available treatment for COVID-19 until today. Although, several drugs are being used as alternative therapeutics against the diseases, mainly in severe cases. This review aimed to highlight the current anti-inflammatory and anticoagulant alternatives treatment measures for control of COVID 19 infection. Here we discuss the drugs, pharmacological proprieties, and the respective studies COVID-19 related, and also, several research protocols to respond and control the pandemic for the prophylaxis and treatment. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-09-28 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.periodicojs.com.br/index.php/hs/article/view/454 10.51249/hes01.04.2021.454 |
url |
https://www.periodicojs.com.br/index.php/hs/article/view/454 |
identifier_str_mv |
10.51249/hes01.04.2021.454 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://www.periodicojs.com.br/index.php/hs/article/view/454/323 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2021 Health and Society info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2021 Health and Society |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Editora Acadêmica Periodicojs |
publisher.none.fl_str_mv |
Editora Acadêmica Periodicojs |
dc.source.none.fl_str_mv |
Health and Society; Vol. 1 No. 04 (2021) Health and Society; v. 1 n. 04 (2021) 2763-5724 10.51249/hs.v1i04 reponame:Health and Society instname:Instituto de Ensino e Pesquisa Periodicojs instacron:IEPP |
instname_str |
Instituto de Ensino e Pesquisa Periodicojs |
instacron_str |
IEPP |
institution |
IEPP |
reponame_str |
Health and Society |
collection |
Health and Society |
repository.name.fl_str_mv |
Health and Society - Instituto de Ensino e Pesquisa Periodicojs |
repository.mail.fl_str_mv |
journalofhealthandsociety@gmail.com || periodicojs@gmail.com |
_version_ |
1797047896064917504 |